YOLFTbeta
Arbutus Biopharma Corp

Arbutus Biopharma Corp

ABUS · NASDAQ · Healthcare / Biotechnology

4.09USD+0.06 (+1.49%)

Price History

Full chart

Market Stats

Previous Close4.03
Open4.04
Day Range3.92 – 4.14
52-Week Range3.50 – 5.45
Volume3.31M
Market Cap966.76M
P/E (TTM)6.18
Forward P/E10.25
EPS0.79
Dividend Yield0.00%
Beta0.62
50-Day Avg4.80
200-Day Avg4.53

About

Arbutus Biopharma Corporation, a clinical-stage biopharmaceutical company, develops novel therapeutics for infectious disease in the United States. Its chronic Hepatitis B virus product pipeline comprises Imdusiran, conjugated GalNAc, subcutaneously-delivered RNAi therapeutic product candidate which is in phase 2a clinical trials that suppresses all HBV antigens, including HBsAg expression; and AB-101, an oral PD-L1 inhibitor, which is in phase 1a/1b clinical trial that has the potential to reawaken patients' HBV-specific immune response by inhibiting PD-L1. The company has licensing agreement with Alnylam Pharmaceuticals, Inc. to develop and commercialize products with LNP delivery technology. The company was formerly known as Tekmira Pharmaceuticals Corporation and changed its name to Arbutus Biopharma Corporation in July 2015. Arbutus Biopharma Corporation was incorporated in 2005 is headquartered in Warminster, Pennsylvania.

Company Details

  • SectorHealthcare
  • IndustryBiotechnology
  • CEOMs. Lindsay Androski J.D., M.B.A.
  • Employees19
  • Headquarters701 Veterans Circle, Warminster, PA, United States, 18974, USA
  • Websitehttps://www.arbutusbio.com

Leadership

  • Ms. Lindsay Androski J.D., M.B.A.President, CEO & Chairman · b. 1977
  • Mr. Tuan NguyenChief Financial Officer · b. 1976
  • Mr. Andrew J. SungGeneral Counsel
  • Mr. R. Hector Mackay-Dunn B.A., J.D., L.L.B., Q.C.Corporate Secretary · b. 1951

Financials

Income Statement

Currency: USD1998-12-311999-12-312000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue1.23M1.14M1.77M3.46M5.07M2.73M12.17M13.29M13.60M15.92M9.64M13.78M21.35M16.30M14.18M15.46M15.00M24.87M1.50M10.70M5.90M6.01M6.91M10.99M39.02M18.14M6.17M14.08M
Growth (%)--7.09%+55.03%+95.68%+46.62%-46.14%+345.43%+9.21%+2.36%+17.05%-39.46%+42.94%+54.95%-23.64%-13.03%+9.05%-3.00%+65.82%-93.97%+613.33%-44.86%+1.88%+15.02%+58.92%+255.11%-53.51%-65.98%+128.21%
Cost of Revenue--10.34M19.14M27.16M30.48M30.05M12.51M6.19M12.79M13.25M16.97M22.13M19.49M18.13M21.46M38.70M51.51M61.30M62.70M57.90M57.60M47.48M1.75M1.43M73.70M1.38M363.00K
Gross Profit1.23M1.14M1.77M3.46M5.07M2.73M12.17M13.29M7.42M15.92M-3.61M-3.19M-779.12K-3.19M-3.94M-5.99M-23.70M-26.63M-59.80M-52.00M-52.00M-51.59M-40.57M10.99M39.02M18.14M6.17M13.72M
Gross Margin100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%54.53%100.00%-37.43%-23.12%-3.65%-19.54%-27.82%-38.76%-158.00%-107.07%-3986.67%-485.98%-881.36%-858.26%-586.74%100.00%100.00%100.00%100.00%97.42%
Operating Expense9.98M9.31M10.97M19.87M32.79M37.38M39.80M19.25M9.10M13.28M7.34M5.88M11.73M7.14M9.05M6.16M9.30M75.69M431.80M58.90M37.80M92.31M17.24M84.51M104.47M96.24M82.49M40.77M
Operating Income-8.75M-8.17M-9.20M-16.41M-27.72M-34.65M-27.63M-5.96M-1.68M2.64M-10.95M-9.07M-12.51M-10.32M-12.99M-12.15M-33.00M-102.32M-491.60M-110.90M-89.80M-143.90M-57.81M-73.52M-65.46M-78.10M-76.32M-27.05M
Operating Margin-713.22%-716.68%-520.56%-474.40%-546.46%-1268.10%-227.08%-44.83%-12.36%16.57%-113.58%-65.79%-58.61%-63.32%-91.62%-78.59%-220.00%-411.38%-32773.33%-1036.45%-1522.03%-2393.96%-836.07%-669.11%-167.75%-430.53%-1236.74%-192.08%
EBITDA-7.76M-6.87M-9.41M-12.57M-22.06M-27.76M-17.90M1.31M20.97M3.05M-7.23M-6.74M-11.05M-9.06M34.18M-11.54M-32.44M-76.72M-488.07M-106.44M-58.95M-162.24M-57.76M-71.64M-61.86M-70.99M-68.40M-33.04M
EBITDA Margin-632.58%-602.29%-532.44%-363.46%-434.95%-1016.02%-147.12%9.85%154.15%19.16%-74.97%-48.88%-51.73%-55.55%241.05%-74.62%-216.29%-308.43%-32538.27%-994.81%-999.20%-2699.10%-835.35%-651.96%-158.54%-391.30%-1108.46%-234.62%
Net Income-8.75M-8.17M-9.20M-14.02M-26.79M-34.08M-28.05M-8.06M18.08M-2.58M-11.72M-9.33M-12.41M-9.73M29.95M-14.06M-38.80M-61.12M-384.10M-84.40M-57.10M-153.72M-63.74M-76.25M-69.46M-72.85M-69.92M-33.50M
Net Income Margin-713.22%-716.68%-520.56%-405.13%-528.27%-1247.26%-230.49%-60.64%132.90%-16.22%-121.56%-67.68%-58.14%-59.69%211.19%-90.95%-258.67%-245.73%-25606.67%-788.79%-967.80%-2557.36%-921.97%-693.91%-178.01%-401.57%-1133.04%-237.88%
R&D8.65M7.75M8.72M12.85M21.61M23.71M22.32M8.76M4.53M8.43M13.25M16.89M22.13T19.51M18.13M21.46M38.70M51.51M61.30M62.70M57.90M57.60M49.34M65.50M84.41M73.70M54.04M25.24M
R&D as % of Total Revenue704.82%679.27%493.01%371.42%426.03%867.68%183.38%65.93%33.27%52.94%137.46%122.54%103665632.51%119.69%127.82%138.76%258.00%207.07%4086.67%585.98%981.36%958.26%713.60%596.12%216.33%406.26%875.66%179.23%
Interest Expense000000001.61M1.02M0156.33K106.94K76.91K47.00K540.00K853.00K674.00K1.39M261.00K200.00K2.11M4.01M2.86M1.73M459.00K137.00K97.00K
Interest Expense % of Total Revenue0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%11.81%6.42%0.00%1.13%0.50%0.47%0.33%3.49%5.69%2.71%92.73%2.44%3.39%35.07%58.01%26.00%4.42%2.53%2.22%0.69%

Balance Sheet

Currency: USD1998-12-311999-12-312000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets15.83M28.80M32.52M67.60M53.22M50.73M41.10M18.50M6.03M24.83M42.34M41.95M21.02M13.70M52.60M71.72M118.20M712.29M275.90M237.20M227.91M105.53M137.08M204.49M195.42M144.40M131.71M94.62M
Total Liabilities1.40M1.92M2.49M6.12M7.87M7.35M51.60M36.99M5.88M6.46M4.05M6.51M10.29M8.50M11.68M12.52M30.20M164.61M72.90M54.70M27.67M32.79M35.11M35.05M58.57M38.38M34.34M18.04M
Total Equity14.43M26.88M30.03M61.49M45.35M43.38M-10.50M-18.49M155.53K18.37M38.29M35.44M10.73M5.21M40.92M59.19M88.00M547.68M203.00M182.50M200.23M72.74M101.97M169.44M136.85M106.02M97.37M76.58M
Cash797.59K10.91M2.05M25.63M20.50M35.56M24.99M10.48M4.87M21.13M21.54M23.30M12.34M9.00M47.03M68.72M72.20M166.78M23.40M54.30M36.94M31.80M52.25M109.28M30.78M26.29M36.33M18.01M
Total Debt-97.77K128.53K355.46K302.81K1.22M1.78M135.09K148.06K76.43K--------18.67M17.97M-3.36M22.54M18.91M12.55M8.72M6.12M4.19M
Net Debt-797.59K-10.81M-1.92M-25.28M-20.20M-34.33M-23.22M-10.35M-4.72M-21.05M-21.54M-23.30M-12.34M-9.00M-47.03M-68.72M-72.20M-166.78M-11.40M-42.30M-36.94M-28.44M-29.71M-90.37M-18.22M-17.56M-30.21M-13.82M

Cash Flow

Currency: USD1998-12-311999-12-312000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-7.71M-6.84M-8.35M-10.00M-18.16M-26.96M-9.98M-14.57M-2.62M-2.72M-8.48M-5.24M-11.25M-7.52M33.27M-6.74M-12.42M-54.78M-57.88M-48.60M-67.90M-71.01M-51.44M-67.53M-35.36M-85.94M-64.85M-39.64M
Investing Cash Flow7.14M-2.99M-13.20M-1.85M2.95M17.02M-4.21M379.86K-80.72K-1.36M3.25M3.85M-830.82K-58.45K-12.40K-725.10K-42.96M7.68M-99.12M27.80M-4.10M28.34M-14.91M-12.68M-74.94M50.77M22.95M15.58M
Financing Cash Flow48.90K19.89M13.07M35.56M9.79M20.60M829.10K-1.20M-2.87M20.29M8.15M7.53K34.91K4.46M4.57M32.72M60.68M143.87M12.64M49.30M55.60M37.46M86.75M137.24M31.81M30.65M52.00M5.72M
Capital Expenditure3.22M300.63K203.64K941.64K1.95M787.73K7.15M45.01K94.87K1.36M966.44K1.62M830.82K58.45K14.90K725.10K1.06M2.29M4.00M7.26M1.14M589.00K229.00K809.00K512.00K1.01M182.00K0
Free Cash Flow-10.93M-7.14M-8.56M-10.95M-20.11M-27.75M-17.13M-14.62M-2.72M-4.08M-9.45M-6.86M-12.08M-7.58M33.26M-7.46M-13.48M-57.07M-61.88M-55.86M-69.04M-71.59M-51.67M-68.34M-35.87M-86.94M-65.03M-39.64M
Dividends Paid--00000000000000000010.09M11.15M12.12M12.14M----
FCF to OCF141.81%104.40%102.44%109.41%110.74%102.92%171.61%100.31%103.62%150.15%111.39%130.98%107.39%100.78%99.96%110.76%108.50%104.17%106.90%114.95%101.68%100.83%100.45%101.20%101.45%101.17%100.28%100.00%
Dividend Paid to FCF--0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%-14.62%-15.57%-23.46%-17.76%----

Earnings

Report DateAug 8, 2007Nov 14, 2007Mar 30, 2008Mar 24, 2009May 13, 2009Aug 12, 2009Mar 17, 2010Aug 12, 2010Nov 15, 2010Mar 30, 2011May 10, 2011Aug 11, 2011Nov 8, 2011Mar 27, 2012May 15, 2012Aug 14, 2012Nov 13, 2012Mar 27, 2013May 14, 2013Aug 12, 2013Nov 13, 2013Mar 6, 2014May 14, 2014Aug 13, 2014Nov 6, 2014Mar 12, 2015May 6, 2015Aug 5, 2015Nov 5, 2015Mar 9, 2016May 4, 2016Aug 4, 2016Nov 3, 2016Mar 21, 2017May 4, 2017Aug 3, 2017Nov 2, 2017Mar 14, 2018May 3, 2018Aug 2, 2018Nov 7, 2018Mar 7, 2019May 6, 2019Aug 5, 2019Nov 6, 2019Mar 5, 2020May 11, 2020Aug 7, 2020Nov 5, 2020Mar 4, 2021May 5, 2021Aug 5, 2021Nov 4, 2021Mar 3, 2022May 5, 2022Aug 4, 2022Nov 9, 2022Mar 2, 2023May 4, 2023Aug 3, 2023Nov 7, 2023Feb 29, 2024May 2, 2024Aug 1, 2024Nov 6, 2024Feb 26, 2025May 14, 2025Aug 6, 2025Nov 13, 2025Feb 26, 2026May 13, 2026Aug 12, 2026Nov 12, 2026
EPS Estimate-0.300.450.05-0.50-0.25-0.15-0.30-0.07-0.04-0.25-0.36-0.30-0.30--0.17-0.16----0.030.050.41-0.28-0.28-0.28-0.50-0.31-0.38-0.40-0.52-0.46-0.57-0.37-0.51-0.53-0.44-0.39-0.53-0.53-0.54-0.40-0.40-0.48-0.39-0.32-0.31-0.31-0.30-0.22-0.30-0.29-0.29-0.19-0.20-0.15-0.18-0.13-0.18-0.14-0.15-0.12-0.15-0.13-0.13-0.12-0.15-0.09-0.05-0.03-0.05-0.03-
EPS Actual-1.050.300.10-0.35-0.20-0.20-0.25-0.080.31-0.11-0.30-0.33-0.12-0.15-0.20-0.18-0.252.70-0.18-0.21-0.42-0.15-0.24-0.01-0.44-0.27-0.43-0.26-0.41-0.06-0.24-0.63-0.42-1.48-0.40-0.41-0.27-0.90-0.46-0.57-0.39-0.37-0.63-0.61-0.51-0.53-0.25-0.33-0.35-0.23-0.26-0.29-0.30-0.15-0.14-0.13-0.16-0.14-0.14-0.13-0.16-0.12-0.14-0.15-0.14-0.10-0.180.01-0.06-0.011.19-0.03-
Surprise-250.00%-33.33%100.00%30.00%20.00%-33.33%16.67%-14.29%875.00%56.00%16.67%-10.00%60.00%--17.65%-12.50%-----1500.00%-400.00%-158.54%96.43%-57.14%3.57%14.00%16.13%-7.89%85.00%53.85%-36.96%26.32%-300.00%21.57%22.64%38.64%-130.77%13.21%-7.55%27.78%7.50%-57.50%-27.08%-30.77%-65.63%19.35%-6.45%-16.67%-4.55%13.33%0.00%-3.45%21.05%30.00%13.33%11.11%-7.69%22.22%7.14%-6.67%0.00%6.67%-15.38%-7.69%14.47%-20.00%111.11%-20.00%54.33%2480.00%0.00%-
Timing-------After-hoursAfter-hoursAfter-hours-Pre-marketAfter-hours-After-hoursAfter-hours-After-hoursAfter-hoursAfter-hoursAfter-hours-After-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketAfter-hoursAfter-hoursAfter-hoursPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-market-Pre-marketPre-market-

Key Statistics & Ratios

Market Cap966.76M
Enterprise Value868.70M
Trailing P/E6.18
Forward P/E10.25
PEG Ratio0.00
Price / Sales5.32
Price / Book3.83
EPS0.79
Book Value1.31
Revenue (TTM)181.72M
Gross Profit (TTM)163.92M
EBITDA147.47M
Profit Margin84.23%
Operating Margin-567.16%
Return on Equity89.58%
Return on Assets48.84%
Shares Outstanding198.11M
Shares Float122.66M
Beta0.62
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Analyst Ratings

Buy
Based on 4 analystsTarget 5.40
  • Strong Buy
    2
  • Buy
    1
  • Hold
    1

Ownership Breakdown

Institutions
72.77%
Insiders
20.40%
Retail / Other
6.83%

Top Institutional Holders

  • Morgan Stanley - Brokerage Accounts
    25.89M13.07%
  • Two Seas Capital LP
    18.56M9.37%
  • Whitefort Capital Management, LP.
    15.79M7.97%
  • BlackRock Inc
    12.97M6.55%
  • Vanguard Capital Management, LLC
    6.69M3.38%
  • Rubric Capital Management LP
    6.63M3.34%
  • State Street Corp
    6.34M3.20%
  • Barclays PLC
    4.32M2.18%
  • Geode Capital Management, LLC
    3.77M1.90%
  • ADAR1 Capital Management LLC
    3.13M1.58%
  • BlackBarn Capital Partners LP
    2.50M1.26%
  • Legal & General Group PLC
    2.40M1.21%
  • Woodline Partners LP
    2.01M1.01%
  • Jefferies Financial Group Inc
    1.89M0.96%
  • Bank of America Corp
    1.68M0.85%

Top Fund Holders

  • Vanguard MStar Total Stk Mkt Idx Invest
    5.03M2.54%
  • iShares Russell 2000 ETF
    4.05M2.04%
  • State Street® SPDR® S&P® Biotech ETF
    3.88M1.96%
  • Morgan Stanley Insight I
    2.73M1.38%
  • Fidelity Small Cap Index
    1.74M0.88%

Stock Splits

  • Nov 4, 20101:5